Study Part NTDemSIB

Name:
SIB-8
Description:
8-item Severe Impairment Battery
Participation:
Responded: 666

Variables - Instruments - References

The Nord-Trøndelag Health Study (HUNT)

HUNT Research Centre
Forskningsveien 2
NO-7600 Levanger
Norway

Tel +47 74 07 51 80
hunt@medisin.ntnu.no
http://www.ntnu.no/hunt/

Organisation and quality assurance of the HUNT data is managed by Arnulf Langhammer and the Databank staff.

HUNT Databank database software development by Jon Heggland.

Variables

Each HUNT variable has a unique name, consisting of two parts separated by @. The first part is called the Topic Name, and indicates what the variable measures or asks about. The second part is called the Study Part Name, and indicates the source of the variable. Both parts are constructed by concatenation of suitable abbreviations selected from a list developed and maintained by HUNT Research Centre.

The Topic Name aims to paraphrase the question text or describe the measurement of the variable in a succinct way. Examples:

Topic NameExpansionQuestion Text / Variable Label
DiaEvDiabetes EverHave you ever had diabetes?
FeelNervLM Feel Nervous Last month During the last month, have you suffered from nervousness (felt irritable, anxious, tense or restless)?
BPDias1Blood Pressure Diastolic 1Diastolic blood pressure, measurement 1

The Study Part Name identifies the Study Part the variable belongs to. A Study Part is a collection of questions, measurements or analyses managed as a unit, e.g. in the form of a questionnaire or interview. The first abbreviation of a Study Part Name indicates which main survey it belongs to: NT1, NT2, NT3, NT4 (for HUNT1-4), YH1, YH2, YH3, YH4 (for the Young-HUNT studies) or others. Other important, frequently occurring abbreviations are Q (Questionnaire), I (Interview), M (Measurements), and BL (Baseline, indicating the common survey packages that the Nord-Trøndelag inhabitants were invited to). Examples:

Study Part NameExpansionStudy Part Description
NT3BLQ1HUNT3 Baseline Questionnaire 1HUNT3 survey main questionnaire
NT2DiaQ HUNT2 Diabetes Questionnaire HUNT2 supplementary questionnaire for diabetics
YH1LuIYoung-HUNT1 Lung InterviewYoung-HUNT1 Lung study interview

Identical or very similar questions/measurements frequently occur in multiple Study Parts, and in such cases the Topic Name is the same. Thus, AstEv@NT2BLQ1 and AstEv@NT3Lu1I both ask if the participant has or has ever had asthma, but the former in the baseline questionnaire of HUNT2, and the latter in the interview of phase 1 of the HUNT3 Lung Study.

SIB#1@NTDemSIB

Question Text:
Skrive navn
English Question Text:
Write your name
Instrument:
SIB8

SIB#2@NTDemSIB

Question Text:
Måned
English Question Text:
What month is it now?
Instrument:
SIB8

SIB#3@NTDemSIB

Question Text:
Måned i året
English Question Text:
Months of the year?
Instrument:
SIB8

SIB#4@NTDemSIB

Question Text:
Setning
English Question Text:
Write a sentence
Instrument:
SIB8

SIB#5@NTDemSIB

Question Text:
Tall hukommelse
English Question Text:
Number memory
Instrument:
SIB8

SIB#6@NTDemSIB

Question Text:
Fluency
English Question Text:
Language fluency
Instrument:
SIB8

SIB#7@NTDemSIB

Question Text:
Konfr. benevning-skje
English Question Text:
What is this? (Given a spoon)
Instrument:
SIB8

SIB#8@NTDemSIB

Question Text:
Bruke skje-bilde
English Question Text:
How would you use this? (Picture of spoon given)
Instrument:
SIB8

SIBUnaReas@NTDemSIB

Question Text:
Årsak til at SIB ikke er gjennomført
English Question Text:
Assessment was not performed, due to
Question Choices:
TextEnglish Text
0AfasiAphasia
1DøvDeaf
2Samarbeider ikkeDoes not cooperate
3AnnetOther
Instrument:
SIB8

Instruments

SIB8

Name:
Severe Impairment Battery 8
Description:
SIB-8 is a brief assessment instrument based on the full Severe Impairment Battery (SIB). Cognitive assessment for people with moderate to severe dementia. Each item is scored 0-2, producing a total score 0-16. A higher score indicates better cognitive functioning
Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study. Int J Clin Pract, 2013. 67(10): p. 1050-6.